Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human TrkA / NTRK1 (33-417) Protein, Mouse IgG2a Fc Tag, 100 µg  

Recombinant Human TrkA / NTRK1 (33-417) Protein, Mouse IgG2a Fc Tag, 100 µg

Recombinant Human TrkA / NTRK1 (33-417) Protein, AA Ala 33 - Gly 417, expressed from human 293 cells (HEK293), Mouse IgG2a Fc Tag

Synonym
recombinant, protein, TrkA, NTRK1, MTC, TRK, TRKA, Trk-A

More details

TRA-H5259-100

390,00 €

Background
Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand. Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors.

Source
Recombinant Human TrkA (33-417), Mouse IgG2a Fc Tag (TRA-H5259) is expressed from human 293 cells (HEK293). It contains AA Ala 33 - Gly 417 (Accession # P04629-2).
Predicted N-terminus: Ala 33

Molecular Characterization
This protein carries a mouse IgG2a Fc tag at the C-terminus.
The protein has a calculated MW of 68.2 kDa. The protein migrates as 80-110 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 0.1 EU per μg by the LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1)  "An Engineered Bionic Nanoparticle Sponge as a Cytokine Trap and Reactive Oxygen Species Scavenger to Relieve Disc Degeneration and Discogenic Pain"
Yang, Li, Pan et al
ACS Nano (2024)
(2)  "Effect of electroacupuncture at Neiguan (PC6) at different time points on myocardial ischemia reperfusion arrhythmia in rats"
Qianhui, Kai, Xingye et al
J Tradit Chin Med (2024) 44 (1), 113-121
(3)  "Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer's disease and the protective role of BDNF"
Zota, Chanoumidou, Charalampopoulos et al
Glia (2024)
Showing 1-3 of 5347 papers.